| Financial Year |
March 31 2023 |
| Monetary Funds |
431,387,698.80 |
| Held-for-trading Financial Assets |
191,956,022.22 |
| Notes Receivable |
62,457,080.23 |
| Accounts Receivable |
329,739,816.14 |
| Advances to Suppliers |
24,393,116.20 |
| Other Receivables |
7,466,013.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
458,388,034.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,730,224.69 |
| Total Current Assets |
1,593,622,806.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
7,531,388.91 |
| Fixed Assetes |
323,307,877.33 |
| Under-construction Projects |
171,971,720.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
201,206,821.31 |
| R&D expenses |
-- |
| Goodwill |
893,070.10 |
| Long-Term Deferred and Prepaid Expenses |
5,059,182.29 |
| Deferred Income Tax Assets |
20,666,024.76 |
| Other Non-Current Assets |
51,764,677.81 |
| Sub-Total of Non-Current Assets |
787,784,291.64 |
| Total Assets |
2,381,407,098.27 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
67,073,697.47 |
| Accounts Payable |
180,846,346.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,434,620.16 |
| Taxes Payable |
6,104,551.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,558,546.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
38,240,599.89 |
| Sub-Total of Current Liabilities |
625,160,284.48 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,000,000.00 |
| Deferred Income Tax Liabilities |
9,902,170.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
64,371,662.13 |
| Total Liabilities |
689,531,946.61 |
| Paid-In Capital(Or Share Stock) |
937,170,000.00 |
| Capital Surplus |
272,304,365.44 |
| Surplus Reserve |
75,821,029.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
371,526,133.49 |
| Minority Stockholder's Interest |
35,053,622.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,656,821,528.83 |
| Owner's Equity（Stockholder's Equity） |
1,691,875,151.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,381,407,098.27 |
